42.46 USD
↗ 1.96 (4.84%)AT CLOSE (11:59 AM EDT)
Vera Therapeutics, Inc. Class A Common Stock
VERANASDAQ • USD
42.94
↗ 0.48 (1.13%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
42.94
↗ 0.48 (1.13%)
Market: CLOSED
Vera Therapeutics, Inc. Class A Common Stock (VERA) trades at $42.46 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, VERA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 26, 2026.
Open?$41.28
High?$43.35
Low?$41.05
Prev. Close?$40.50
Volume?4.2M
Avg. Volume?1.4M
VWAP?$42.41
Rel. Volume?3.03x
Bid / Ask
Bid?$42.76 × 100
Ask?$43.05 × 100
Spread?$0.29
Midpoint?$42.91
Valuation & Ratios
Market Cap?3.0B
Shares Out?71.8M
Float?62.9M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?6.10
EPS?-$5.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Address
2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE, CA 94005
Phone: 650-770-0077
BRISBANE, CA 94005
Phone: 650-770-0077
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?14
Piotroski F-Score?0/9Weak
Altman Z-Score?12.07Safe
Confidence?49%Low
Short InterestVery High
Short % of Float?18.82%High
Short Interest?11.8M
Days to Cover?10.4
Free Float62.9M
Avg Daily Volume1.1M
Settlement Date2026-06-15
Financial Health
Current Ratio?13.64Strong
Quick Ratio?13.64Strong
Cash Ratio?2.53Strong
Debt/Equity?0.15Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?6.10FAIR▾
Peers100
S&P30
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-74.0%WEAK▾
S&P3
ROA?-59.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-293814000
Enterprise Value?$3.0B
Fundamentals ratios updated end of day